BIIB : Summary for Biogen Inc. - Yahoo Finance

U.S. Markets close in 2 hrs 52 mins

Biogen Inc. (BIIB)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
279.12-0.86 (-0.31%)
As of 1:07PM EDT. Market open.
People also watch
CELGGILDREGNAMGNALXN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close279.98
Open279.57
Bid279.33 x 100
Ask279.38 x 100
Day's Range278.25 - 281.22
52 Week Range223.02 - 333.65
Volume1,123,985
Avg. Volume1,642,474
Market Cap60.28B
Beta0.51
PE Ratio (TTM)16.49
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Biogen, Inc. :BIIB-US: Earnings Analysis: Q1, 2017 By the Numbers : April 27, 2017
    Capital Cube2 hours ago

    Biogen, Inc. :BIIB-US: Earnings Analysis: Q1, 2017 By the Numbers : April 27, 2017

    Categories: Yahoo FinanceGet free summary analysis Biogen, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Biogen, Inc. – Johnson & Johnson (JNJ-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 2,480.50 million, Net Earnings of USD 747.60 million. Gross ... Read more (Read more...)

  • Market Realist2 hours ago

    Biogen Still Dominated the Multiple Sclerosis Market in 1Q17

    Biogen witnessed a slight contraction in demand for its MS products in the US market in 1Q17 on a quarter-over-quarter basis.

  • Market Realist4 hours ago

    Analysts’ Recommendations for Biogen in 1Q17

    Biogen (BIIB) currently holds a 38.0% share of the global MS market. In 1Q17, the company reported revenues of around $2.2 billion for its MS franchise